Cargando...
Mirtazapine-associated movement disorders: A literature review
Mirtazapine (MTZ) is an atypical antidepressant approved by the FDA, which mechanism of action involves the antagonism of alpha-2, H1, 5-HT2A, 5-HT2C, and 5-HT3 receptors. In this context, the aim of this literature review is to evaluate the clinical epidemiological profile, pathological mechanisms,...
Gardado en:
| Publicado en: | Tzu Chi Med J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7605300/ https://ncbi.nlm.nih.gov/pubmed/33163376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tcmj.tcmj_13_20 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|